Instantaneous Wave-Free Ratio (iFR) is an advanced coronary physiology test used to determine whether a narrowing in a coronary artery is significantly restricting blood flow to the heart muscle. It is particularly useful when coronary angiography shows a blockage of uncertain severity and the cardiologist needs more information before deciding whether treatment such as angioplasty or stenting is appropriate. iFR measures the pressure difference across a coronary artery narrowing during a specific part of the heartbeat called the “wave-free period.” Unlike Fractional Flow Reserve (FFR), iFR is performed under resting conditions and does not routinely require medication to artificially increase blood flow.
iFR itself is not a disease and therefore does not have specific causes. It is a diagnostic technique used when coronary artery disease may have caused narrowing or obstruction within the coronary arteries. Such narrowing most commonly develops because of atherosclerosis, in which fatty deposits and plaque build up inside the artery walls. Intermediate blockages may not always be accurately classified by angiography alone, making physiological assessment such as iFR valuable for determining whether the narrowing is actually affecting blood supply to the heart.
The symptoms that may lead a cardiologist to consider iFR are generally related to possible coronary artery disease rather than the iFR test itself. Patients may experience chest pain or pressure, particularly during physical activity, breathlessness, unusual fatigue, reduced exercise tolerance, or discomfort that may radiate to the arm, shoulder, back, neck, or jaw. Some patients with coronary artery narrowing may have few or no obvious symptoms, which is why clinical assessment and appropriate cardiac investigations are important when coronary disease is suspected.
iFR is performed during coronary angiography or cardiac catheterization. A specialised pressure-sensitive guidewire is carefully positioned beyond the coronary artery narrowing, allowing the cardiologist to compare the pressure inside the coronary artery with the pressure in the aorta during the wave-free period of diastole. An iFR value of 0.89 or below is generally considered indicative of a haemodynamically significant coronary narrowing and may support revascularization when appropriate. Values above this threshold often support treatment with medication rather than an immediate coronary intervention, although the final decision depends on the patient’s symptoms, clinical findings, angiographic appearance, and overall cardiac condition.
iFR is a diagnostic assessment rather than a treatment by itself. Its results can help guide an individualized treatment plan. If the assessment suggests that a coronary narrowing is not significantly restricting blood flow, unnecessary stenting may be avoided and the patient may instead be managed with appropriate medication, lifestyle modification, and control of cardiovascular risk factors. When a narrowing is found to be physiologically significant and the clinical circumstances support intervention, treatment may include percutaneous coronary intervention (PCI), such as angioplasty and stent placement. The choice between medical management and revascularization depends on the patient’s symptoms, coronary anatomy, overall cardiovascular risk, and clinical assessment.
After an iFR-guided evaluation or coronary intervention, follow-up care focuses on protecting long-term heart health and reducing the risk of further coronary artery disease. Patients should take prescribed medicines consistently and attend scheduled cardiology follow-ups. Maintaining a heart-healthy diet, engaging in appropriate physical activity, avoiding tobacco, managing blood pressure, cholesterol and blood sugar, and maintaining a healthy weight are important components of ongoing cardiovascular care. If a stent has been placed, adherence to prescribed antiplatelet medication is particularly important, and patients should never stop such medication without consulting their cardiologist. Long-term management and risk-factor control remain important even when symptoms improve.
Because iFR is generally performed as part of coronary angiography, its risks are related mainly to the invasive catheter-based procedure rather than the measurement itself. Possible complications can include temporary discomfort or bruising at the catheter entry site, bleeding, infection, an allergic reaction to contrast material, abnormal heart rhythms, blood-vessel injury, or, rarely, more serious cardiovascular complications. Your cardiologist will consider your medical history, kidney function, medications, allergies, and overall health before recommending the procedure and will take appropriate precautions to minimize these risks.
You should consult a cardiologist if you experience recurring chest discomfort, unexplained breathlessness, unusual fatigue, reduced exercise tolerance, or other symptoms that could indicate reduced blood flow to the heart. An iFR assessment may be recommended when coronary angiography identifies a narrowing and its functional significance needs to be clarified before deciding on treatment. If you develop sudden or severe chest pressure, difficulty breathing, cold sweating, fainting, or pain spreading to the arm, jaw, back, or shoulder, seek emergency medical attention immediately, as these can be warning signs of an acute cardiac event.
Explore More: Intra-Aortic Balloon Pump (IABP) Support
Providing advanced, compassionate and evidence-based cardiac care with a focus on interventional cardiology, structural heart procedures and comprehensive heart health.
9:00 AM – 6:00 PM (By Appointment Only)
